PS Ratio
6.51
+0.02+0.31%
Fri, 27 Dec 2024 22:38:13 GMT
Summary:
Halozyme Therapeutics price to sales ratio is currently 6.51, with a rise of +0.02 (+0.31%) during the most recent trading day. Over the past year, it has increased by +0.28 (+4.49%). HALO PS ratio is now -99.73% below its all-time high of 2405.17.HALO PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO PS Ratio Performance
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +0.3% | +0.3% | +0.3% | +8.5% |
| 1 m1 month | -0.6% | -0.7% | -0.7% | - |
| 3 m3 months | -21.1% | -14.8% | -14.4% | - |
| 6 m6 months | -12.6% | -4.0% | -4.1% | - |
| ytdytd | +15.2% | +31.1% | +31.6% | - |
| 1 y1 year | +4.5% | +31.7% | +26.8% | +21.4% |
| 5 y5 years | -50.0% | +169.6% | +134.1% | +367.7% |
HALO PS Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 6.71 | -3.0% | 6.21 | +4.8% |
| 3 m | 3 months | 8.39 | -22.4% | 5.75 | +13.2% |
| 6 m | 6 months | 9.43 | -31.0% | 5.75 | +13.2% |
| 1 y | 1 year | 9.43 | -31.0% | 5.04 | +29.2% |
| 3 y | 3 years | 14.62 | -55.5% | 5.04 | +29.2% |
| 5 y | 5 years | 29.55 | -78.0% | 5.04 | +29.2% |
| alltime | all time | 2405.17 | -99.7% | 5.04 | +29.2% |
Halozyme Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2024 | 6.51(+15.2%) |
| 2023 | 5.65(-51.4%) |
| 2022 | 11.63(-6.7%) |
| 2021 | 12.47(-42.1%) |
| 2020 | 21.55(+74.2%) |
| 2019 | 12.37(-11.3%) |
| 2018 | 13.94(+52.5%) |
| 2017 | 9.14(+4.8%) |
| 2016 | 8.72(-47.0%) |
| 2015 | 16.44(+2.1%) |
| Date | Value |
|---|---|
| 2014 | 16.10(-48.6%) |
| 2013 | 31.33(+75.3%) |
| 2012 | 17.87(+1.4%) |
| 2011 | 17.63(-69.8%) |
| 2010 | 58.47(+48.6%) |
| 2009 | 39.36(-24.4%) |
| 2008 | 52.04(-64.3%) |
| 2007 | 145.78(-74.1%) |
| 2006 | 563.59(-34.6%) |
| 2005 | 862.02 |
FAQ
- What is Halozyme Therapeutics price to sales ratio?
- What is the all time high PS ratio for Halozyme Therapeutics?
- What is HALO price to sales ratio year-to-date change?
- What is Halozyme Therapeutics PS ratio year-on-year change?
What is Halozyme Therapeutics price to sales ratio?
The current PS ratio of HALO is 6.51
What is the all time high PS ratio for Halozyme Therapeutics?
Halozyme Therapeutics all-time high price to sales ratio is 2405.17
What is HALO price to sales ratio year-to-date change?
Halozyme Therapeutics price to sales ratio has changed by +0.86 (+15.22%) since the beginning of the year
What is Halozyme Therapeutics PS ratio year-on-year change?
Over the past year, HALO price to sales ratio has changed by +0.28 (+4.49%)